Xintela AB (publ) (STO:XINT)
Sweden · Delayed Price · Currency is SEK 0.2090
+0.0030 (1.46%)
Jun 11, 2026, 4:25 PM CET
Xintela AB Market Cap
Xintela AB has a market cap or net worth of 180 million as of June 11, 2026. Its market cap has decreased by -43.68% in one year.
Market Cap
180.00M
Enterprise Value
170.22M
Revenue
2.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.21
Market Cap Chart
Since March 22, 2016, Xintela AB's market cap has increased from 103.68M to 180.00M, an increase of 73.61%. That is a compound annual growth rate of 5.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 177.42M | -10.70% |
| Dec 30, 2025 | 198.68M | 5.85% |
| Dec 30, 2024 | 187.69M | 26.87% |
| Dec 29, 2023 | 147.94M | -1.74% |
| Dec 30, 2022 | 150.56M | -26.24% |
| Dec 30, 2021 | 204.12M | 2.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Isofol Medical AB | 224.99M |
| Xbrane Biopharma AB | 221.51M |
| Nanologica AB | 182.80M |
| Initiator Pharma | 179.35M |
| Diamyd Medical AB | 172.65M |
| Elicera Therapeutics AB | 162.84M |
| Active Biotech AB | 158.16M |
| Alligator Bioscience AB | 126.88M |